Unsurprisingly, MYC overexpression in BL cells results in many metabolic features known to be driven by MYC including increased glucose consumption and lactate production, but also increased contribution of glucose-derived carbon to the TCA cycle [49]. The gene discussed is MYC; the disease is Burkitt lymphoma.